ERT's MasterScope® 2 Deployed in Respiratory Clinical Trials

June 15, 2015

ERT, a global provider of patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions, announced that MasterScope® 2, its comprehensive diagnostic platform for spirometry, electrocardiogram (ECG) and home monitoring, has been successfully implemented with 350 investigative sites.

ERT, a global provider of patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions, announced that MasterScope® 2, its comprehensive diagnostic platform for spirometry, electrocardiogram (ECG) and home monitoring, has been successfully implemented with 350 investigative sites currently enrolling patients using the advancedMasterScope 2 platform. The platform collects   processes trial endpoint data for spirometry combined with ERT’s AM3 GSM home spirometry, eDiary and the new, integrated12-lead digital ECG. One study is also taking advantage of MasterScope’s seamless integration of the Aerocrine NIOX Mino® capturing exhaled nitric oxide (FeNO).

 

Read the full release.